BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32651213)

  • 1. Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk.
    Wang X; Su YR; Petersen PS; Bien S; Schmit SL; Drew DA; Albanes D; Berndt SI; Brenner H; Campbell PT; Casey G; Chang-Claude J; Gallinger SJ; Gruber SB; Haile RW; Harrison TA; Hoffmeister M; Jacobs EJ; Jenkins MA; Joshi AD; Li L; Lin Y; Lindor NM; Marchand LL; Martin V; Milne R; Maclnnis R; Moreno V; Nan H; Newcomb PA; Potter JD; Rennert G; Rennert H; Slattery ML; Thibodeau SN; Weinstein SJ; Woods MO; Chan AT; White E; Hsu L; Peters U
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1800-1808. PubMed ID: 32651213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.
    Nan H; Hutter CM; Lin Y; Jacobs EJ; Ulrich CM; White E; Baron JA; Berndt SI; Brenner H; Butterbach K; Caan BJ; Campbell PT; Carlson CS; Casey G; Chang-Claude J; Chanock SJ; Cotterchio M; Duggan D; Figueiredo JC; Fuchs CS; Giovannucci EL; Gong J; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hudson TJ; Jenkins MA; Jiao S; Lindor NM; Lemire M; Le Marchand L; Newcomb PA; Ogino S; Pflugeisen BM; Potter JD; Qu C; Rosse SA; Rudolph A; Schoen RE; Schumacher FR; Seminara D; Slattery ML; Thibodeau SN; Thomas F; Thornquist M; Warnick GS; Zanke BW; Gauderman WJ; Peters U; Hsu L; Chan AT; ;
    JAMA; 2015 Mar; 313(11):1133-42. PubMed ID: 25781442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer.
    Drew DA; Kim AE; Lin Y; Qu C; Morrison J; Lewinger JP; Kawaguchi E; Wang J; Fu Y; Zemlianskaia N; Díez-Obrero V; Bien SA; Dimou N; Albanes D; Baurley JW; Wu AH; Buchanan DD; Potter JD; Prentice RL; Harlid S; Arndt V; Barry EL; Berndt SI; Bouras E; Brenner H; Budiarto A; Burnett-Hartman A; Campbell PT; Carreras-Torres R; Casey G; Chang-Claude J; Conti DV; Devall MAM; Figueiredo JC; Gruber SB; Gsur A; Gunter MJ; Harrison TA; Hidaka A; Hoffmeister M; Huyghe JR; Jenkins MA; Jordahl KM; Kundaje A; Le Marchand L; Li L; Lynch BM; Murphy N; Nassir R; Newcomb PA; Newton CC; Obón-Santacana M; Ogino S; Ose J; Pai RK; Palmer JR; Papadimitriou N; Pardamean B; Pellatt AJ; Peoples AR; Platz EA; Rennert G; Ruiz-Narvaez E; Sakoda LC; Scacheri PC; Schmit SL; Schoen RE; Stern MC; Su YR; Thomas DC; Tian Y; Tsilidis KK; Ulrich CM; Um CY; van Duijnhoven FJB; Van Guelpen B; White E; Hsu L; Moreno V; Peters U; Chan AT; Gauderman WJ
    Sci Adv; 2024 May; 10(22):eadk3121. PubMed ID: 38809988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk.
    Wang X; Chan AT; Slattery ML; Chang-Claude J; Potter JD; Gallinger S; Caan B; Lampe JW; Newcomb PA; Zubair N; Hsu L; Schoen RE; Hoffmeister M; Brenner H; Le Marchand L; Peters U; White E
    Cancer Res; 2018 Aug; 78(16):4790-4799. PubMed ID: 29921691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta.
    Siezen CL; Tijhuis MJ; Kram NR; van Soest EM; de Jong DJ; Fodde R; van Kranen HJ; Kampman E
    Pharmacogenet Genomics; 2006 Jan; 16(1):43-50. PubMed ID: 16344721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk.
    Xia Z; Su YR; Petersen P; Qi L; Kim AE; Figueiredo JC; Lin Y; Nan H; Sakoda LC; Albanes D; Berndt SI; Bézieau S; Bien S; Buchanan DD; Casey G; Chan AT; Conti DV; Drew DA; Gallinger SJ; Gauderman WJ; Giles GG; Gruber SB; Gunter MJ; Hoffmeister M; Jenkins MA; Joshi AD; Le Marchand L; Lewinger JP; Li L; Lindor NM; Moreno V; Murphy N; Nassir R; Newcomb PA; Ogino S; Rennert G; Song M; Wang X; Wolk A; Woods MO; Brenner H; White E; Slattery ML; Giovannucci EL; Chang-Claude J; Pharoah PDP; Hsu L; Campbell PT; Peters U
    Cancer Med; 2020 May; 9(10):3563-3573. PubMed ID: 32207560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk.
    Khankari NK; Banbury BL; Borges MC; Haycock P; Albanes D; Arndt V; Berndt SI; Bézieau S; Brenner H; Campbell PT; Casey G; Chan AT; Chang-Claude J; Conti DV; Cotterchio M; English DR; Figueiredo JC; Giles GG; Giovannucci EL; Gunter MJ; Hampe J; Hoffmeister M; Hopper JL; Jenkins MA; Joshi AD; Marchand LL; Lemire M; Li CI; Li L; Lindblom A; Martín V; Moreno V; Newcomb PA; Offit K; Pharoah PDP; Rennert G; Sakoda LC; Schafmayer C; Schmit SL; Slattery ML; Song M; Thibodeau SN; Ulrich CM; Weinstein SJ; White E; Win AK; Wolk A; Woods MO; Wu AH; Cai Q; Denny JC; Edwards TL; Murff HJ; Gruber SB; Peters U; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2020 Apr; 29(4):860-870. PubMed ID: 32051193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of microsatellite-unstable colorectal cancer is associated jointly with smoking and nonsteroidal anti-inflammatory drug use.
    Chia VM; Newcomb PA; Bigler J; Morimoto LM; Thibodeau SN; Potter JD
    Cancer Res; 2006 Jul; 66(13):6877-83. PubMed ID: 16818666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
    Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin Sulphate and Glucosamine Use Depend on Nonsteroidal Anti-inflammatory Drug Use to Modify the Risk for Colorectal Cancer.
    Ibáñez-Sanz G; Guinó E; Morros R; Quijada-Manuitt MÁ; de la Peña-Negro LC; Moreno V
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1809-1816. PubMed ID: 32651216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in TP53, nonsteroidal anti-inflammatory drugs and the risk of colorectal cancer: evidence for gene-environment interaction?
    Tan XL; Nieters A; Hoffmeister M; Beckmann L; Brenner H; Chang-Claude J
    Pharmacogenet Genomics; 2007 Aug; 17(8):639-45. PubMed ID: 17622940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer.
    Andersen V; Vogel U
    Aliment Pharmacol Ther; 2014 Jul; 40(2):147-59. PubMed ID: 24889212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.
    Scherer D; Koepl LM; Poole EM; Balavarca Y; Xiao L; Baron JA; Hsu L; Coghill AE; Campbell PT; Kleinstein SE; Figueiredo JC; Lampe JW; Buck K; Potter JD; Kulmacz RJ; Jenkins MA; Hopper JL; Win AK; Newcomb PA; Ulrich CM; Makar KW
    Genes Chromosomes Cancer; 2014 Jul; 53(7):568-78. PubMed ID: 24677636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer: A Population-Based Case-Control Study.
    Kuo CN; Pan JJ; Huang YW; Tsai HJ; Chang WC
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):737-745. PubMed ID: 29695380
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
    Peleg II; Maibach HT; Brown SH; Wilcox CM
    Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intake of Red and Processed Meat, Use of Non-Steroid Anti-Inflammatory Drugs, Genetic Variants and Risk of Colorectal Cancer: A Prospective Study of the Danish "Diet, Cancer and Health" Cohort.
    Andersen V; Halekoh U; Tjønneland A; Vogel U; Kopp TI
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.
    Kleinstein SE; Heath L; Makar KW; Poole EM; Seufert BL; Slattery ML; Xiao L; Duggan DJ; Hsu L; Curtin K; Koepl L; Muehling J; Taverna D; Caan BJ; Carlson CS; Potter JD; Ulrich CM
    Genes Chromosomes Cancer; 2013 May; 52(5):437-49. PubMed ID: 23404351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
    Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.
    Slattery ML; Samowitz W; Hoffman M; Ma KN; Levin TR; Neuhausen S
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):538-45. PubMed ID: 15066917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.
    García-Rodríguez LA; Huerta-Alvarez C
    Epidemiology; 2001 Jan; 12(1):88-93. PubMed ID: 11138826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.